Trials / Completed
CompletedNCT00000231
Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13
Buprenorphine Detoxification With Two Types of Treatment. BBD IV
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with pro-social activities. In addition, we will examine whether blind naltrexone dosing is effective in indicating naltrexone consumption.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine |
Timeline
- Start date
- 1992-02-01
- First posted
- 1999-09-21
- Last updated
- 2005-08-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000231. Inclusion in this directory is not an endorsement.